Talecris Biotherapeutics' comprehensive safety and quality management programs have ensured that our albumin products continue to exhibit an excellent safety record with no confirmed pathogen transmission in over six decades. The breadth and depth of these measures demonstrate Talecris Biotherapeutics' ongoing commitment to the patients who rely on albumin products.
These methods include:
 |
 |
Regular inspection of plasma donor centers, three to six times each year
|
|
Strict screening of plasma donors
|
|
Complete donor documentation, including medical exam and history
|
|
State-of-the-art test methods, including PCR testing for viruses and Western blot assay (PDF) for prion clearance
|
|
Four distinct effective steps that complement each other in their mechanism of virus reduction, including Talecris' exclusive Acetone Suspension Step
|
|
Continuous quality control
|
|
|